Cargando…
Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder worldwide. Progressive loss of dopaminergic neurons in the substantia nigra (SN) and their synaptic terminal connections in the striatum are main characterizations of PD. Although many efforts have been made to develop the...
Autores principales: | Baek, Hyunjung, Jang, Hyun Il, Jeon, Hat Nim, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004420/ https://www.ncbi.nlm.nih.gov/pubmed/29942256 http://dx.doi.org/10.3389/fnagi.2018.00179 |
Ejemplares similares
-
Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A(2) Against MPTP-Induced Parkinson’s Disease in Mice
por: Kim, Kyung Hwa, et al.
Publicado: (2019) -
Comparison of the Protective Effects of Bee Venom Extracts with Varying PLA(2) Compositions in a Mouse Model of Parkinson’s Disease
por: Kim, Kyung Hwa, et al.
Publicado: (2019) -
Protective Effects of Intratracheally-Administered Bee Venom Phospholipase A2 on Ovalbumin-Induced Allergic Asthma in Mice
por: Jung, Kyung-Hwa, et al.
Publicado: (2016) -
Prophylactic Effects of Bee Venom Phospholipase A2 in Lipopolysaccharide-Induced Pregnancy Loss
por: Baek, Hyunjung, et al.
Publicado: (2019) -
Bee Venom Phospholipase A2 Induces Regulatory T Cell Populations by Suppressing Apoptotic Signaling Pathway
por: Baek, Hyunjung, et al.
Publicado: (2020)